TrialJournal for immunotherapy of cancer2024

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.

Joseph J Sacco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.